Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy

W. van den Ancker; J.M. Ruben; T.M. Westers; D. Wulandari; H.J. Bontkes; E. Hooijberg; A.G.M. Stam; S.J.A.M. Santegoets; G.J. Ossenkoppele; T.D. de Gruijl; A.A. van de Loosdrecht

doi:https://doi.org/10.4161/onci.23971

Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy

W. van den Ancker, J.M. Ruben, T.M. Westers, D. Wulandari, H.J. Bontkes, E. Hooijberg, A.G.M. Stam, S.J.A.M. Santegoets, G.J. Ossenkoppele, T.D. de Gruijl, A.A. van de Loosdrecht

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Original language	Undefined/Unknown
Article number	e23971
Journal	Oncoimmunology
Volume	2
Issue number	4
DOIs	https://doi.org/10.4161/onci.23971
Publication status	Published - 2013

Access to Document

https://doi.org/10.4161/onci.23971

Cite this

van den Ancker, W., Ruben, J. M., Westers, T. M., Wulandari, D., Bontkes, H. J., Hooijberg, E., Stam, A. G. M., Santegoets, S. J. A. M., Ossenkoppele, G. J., de Gruijl, T. D., & van de Loosdrecht, A. A. (2013). Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy. Oncoimmunology, 2(4), [e23971]. https://doi.org/10.4161/onci.23971

@article{deb2f278023d4b319aa68d7850d59c0c,

title = "Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy",

author = "{van den Ancker}, W. and J.M. Ruben and T.M. Westers and D. Wulandari and H.J. Bontkes and E. Hooijberg and A.G.M. Stam and S.J.A.M. Santegoets and G.J. Ossenkoppele and {de Gruijl}, T.D. and {van de Loosdrecht}, A.A.",

year = "2013",

doi = "https://doi.org/10.4161/onci.23971",

language = "Undefined/Unknown",

volume = "2",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Landes Bioscience",

number = "4",

}

van den Ancker, W, Ruben, JM, Westers, TM, Wulandari, D, Bontkes, HJ, Hooijberg, E, Stam, AGM, Santegoets, SJAM, Ossenkoppele, GJ , de Gruijl, TD & van de Loosdrecht, AA 2013, 'Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy', Oncoimmunology, vol. 2, no. 4, e23971. https://doi.org/10.4161/onci.23971

TY - JOUR

T1 - Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy

AU - van den Ancker, W.

AU - Ruben, J.M.

AU - Westers, T.M.

AU - Wulandari, D.

AU - Bontkes, H.J.

AU - Hooijberg, E.

AU - Stam, A.G.M.

AU - Santegoets, S.J.A.M.

AU - Ossenkoppele, G.J.

AU - de Gruijl, T.D.

AU - van de Loosdrecht, A.A.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.4161/onci.23971

DO - https://doi.org/10.4161/onci.23971

M3 - Article

C2 - 23734332

SN - 2162-4011

VL - 2

JO - OncoImmunology

JF - OncoImmunology

IS - 4

M1 - e23971

ER -